News

It’s important to continuously look forward to our role in serving all patients and colleagues—especially those who are underrepresented.

This week's edition of the Mainstream Patient features stories about sensitive skin around the eyes, health risks of sharing razors, keratin shampoos for stronger hair, and more.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses botox and other cosmetic treatments with Matthew Elias, DO, FAAD.

Explore a collection of the best skin tips for patients with skin of color.

Granulomatous dermatitis includes a group of reactive dermatologic disorders characterized by distinct histopathological patterns, clinical manifestations, and associated diseases.

Learn more about what in-depth topics were covered in the January 2023 issue of Dermatology Times.

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are popular for the month of January.

Pemphigus is defined as a group of autoimmune, blistering disorders caused by circulating autoantibodies that bind to desmogleins, proteins that are vital to epidermal intercellular adhesion.

Christopher Bunick, MD, PhD, and Raj Chovatiya, MD, PhD, discuss the benefits of adalimumab-atto and the future of additional biosimilars in 2023.

Preventing generalized pustular psoriasis may be possible based on recent data.

Click here to answer this week's poll.

This review will explore various leukemia-related cutaneous findings and discuss the diagnosis and management of these conditions.

ICYMI, this week we had stories about conference coverage from Winter Clinical Hawaii, generalized pustular psoriasis management, nutritional supplements for hair loss, and more.

Dermatologists have long warned tan seekers about the detrimental effects of ultraviolet exposure and tanning beds, strongly discouraging their use; nasal tanning sprays are no different.

List prices of 450 medications have increased 5% overall at the beginning of 2023. More price hikes are expected.

Breakthroughs and approvals we can expect in the coming year.

Union therapeutics is also developing the drug for treatment of atopic dermatitis and hidradenitis suppurativa.

ICYMI, this week we had stories about what to look forward to in 2023, psoriasis challenges, NDA submissions for berdazimer gel, and more.

Answers to some common questions about providing telehealth services in 2023.

The Dermatology Times® Editorial Advisory Board members share what they hope to see in 2023.

ICYMI, this week we had stories about the top 5 articles of 2022, adjuvant treatment for Merkel cell carcinoma, favorite skin care products of 2022, and more.

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of December.

A look back at benzene found in personal care products throughout the year and how companies have responded.

Dermatology Times®’ Editorial Board offers insight on what they loved about 2022, and what they hope to see in 2023.

As 2022 comes to a close, take a look at the top 5 articles from the year.

ICYMI, this week we had stories about roflumilast cream for plaque psoriasis, a conversation about JAK inhibitors for atopic dermatitis, mental health related to vitiligo, and more.

Arcutis Biotherapeutics' indication expansion is based on data from MUSE studies.

ICYMI, this week we had stories about holistic treatment for atopic dermatitis management, a recap of the 2022 Revolutionizing Atopic Dermatitis Conference, unmet needs in acne management, and more.

The PharmaJet Stratis Needle-free Injection System’s vaccine could help prevent a rare but aggressive form of skin cancer.

ICYMI, this week we had stories about the upcoming 2023 South Beach Symposium Meeting, acetic acid for wound healing, CBD for acne treatment, and more.